| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |